These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21897267)

  • 1. Association of keap1 and nrf2 genetic mutations and polymorphisms with endometrioid endometrial adenocarcinoma survival.
    Wong TF; Yoshinaga K; Monma Y; Ito K; Niikura H; Nagase S; Yamamoto M; Yaegashi N
    Int J Gynecol Cancer; 2011 Nov; 21(8):1428-35. PubMed ID: 21897267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features.
    Solis LM; Behrens C; Dong W; Suraokar M; Ozburn NC; Moran CA; Corvalan AH; Biswal S; Swisher SG; Bekele BN; Minna JD; Stewart DJ; Wistuba II
    Clin Cancer Res; 2010 Jul; 16(14):3743-53. PubMed ID: 20534738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer.
    Gao L; Yuan F; Che G; Xiao X; Nie X; Wang Y; Jia J; Kong AN; Zhang L
    J Cell Biochem; 2019 Aug; 120(8):12311-12320. PubMed ID: 30825237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of hormone-dependent breast cancer seems to be influenced by KEAP1, NRF2 and GSTM1 genetic polymorphisms.
    Almeida M; Soares M; Ramalhinho AC; Moutinho JF; Breitenfeld L
    Mol Biol Rep; 2019 Jun; 46(3):3213-3224. PubMed ID: 30941643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer.
    Konstantinopoulos PA; Spentzos D; Fountzilas E; Francoeur N; Sanisetty S; Grammatikos AP; Hecht JL; Cannistra SA
    Cancer Res; 2011 Aug; 71(15):5081-9. PubMed ID: 21676886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma.
    Danilovic DLS; de Mello ES; Frazzato EST; Wakamatsu A; de Lima Jorge AA; Hoff AO; Marui S
    Head Neck; 2018 Jun; 40(6):1271-1278. PubMed ID: 29469959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
    Singh A; Misra V; Thimmulappa RK; Lee H; Ames S; Hoque MO; Herman JG; Baylin SB; Sidransky D; Gabrielson E; Brock MV; Biswal S
    PLoS Med; 2006 Oct; 3(10):e420. PubMed ID: 17020408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy.
    Liu Z; Yin X; Liu L; Tao H; Zhou H; Ma G; Cui L; Li Y; Zhang S; Xu Z; Yao L; Cai Z; Zhao B; Li K
    Gene; 2015 Oct; 571(2):231-6. PubMed ID: 26149655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of the Nrf2 pathway in colorectal cancer: Nrf2 expression is closely correlated to Keap1 in the tumor and Bach1 in the normal tissue.
    Chang LC; Fan CW; Tseng WK; Chen JR; Chein HP; Hwang CC; Hua CC
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):511-7. PubMed ID: 23455180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression Patterns of Nrf2 and Keap1 in Ovarian Cancer Cells and their Prognostic Role in Disease Recurrence and Patient Survival.
    Cho HY; Kim K; Kim YB; Kim H; No JH
    Int J Gynecol Cancer; 2017 Mar; 27(3):412-419. PubMed ID: 28129239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas.
    Beinse G; Just PA; Rance B; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Pasmant E; Batteux F; Borghese B; Alexandre J; Leroy K
    PLoS One; 2019; 14(3):e0214416. PubMed ID: 30908539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of the Keap1-Nrf2 pathway in cancer.
    Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
    Biochem Soc Trans; 2015 Aug; 43(4):645-9. PubMed ID: 26551706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic Keap1 Expression Is Associated With Poor Prognosis in Endometrial Cancer.
    Ahtikoski AM; Kangas J; Salonen R; Puistola U; Karihtala P
    Anticancer Res; 2019 Feb; 39(2):585-590. PubMed ID: 30711933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma.
    Cescon DW; She D; Sakashita S; Zhu CQ; Pintilie M; Shepherd FA; Tsao MS
    Clin Cancer Res; 2015 Jun; 21(11):2499-505. PubMed ID: 25739673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma.
    Li QK; Singh A; Biswal S; Askin F; Gabrielson E
    J Hum Genet; 2011 Mar; 56(3):230-4. PubMed ID: 21248763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KEAP1/NRF2 signaling pathway mutations in cervical cancer.
    Chu XY; Li ZJ; Zheng ZW; Tao YL; Zou FX; Yang XF
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4458-4466. PubMed ID: 30058679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
    Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
    PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel Nrf2/Keap1 pathway mutations in pediatric acute lymphoblastic leukemia.
    Akın-Balı DF; Aktas SH; Unal MA; Kankılıc T
    Pediatr Hematol Oncol; 2020 Feb; 37(1):58-75. PubMed ID: 31661353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs.
    Fabrizio FP; Sparaneo A; Trombetta D; Muscarella LA
    Oxid Med Cell Longev; 2018; 2018():2492063. PubMed ID: 29643973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.